Skip to Main Content
Table 1.

BrdU incorporation rates in germline and follicle cell dm2 clones

Genotype
FRT18D/FRT18Ddm2 18D/dm2 18D
Germline clones stage 5-8 28% (n=630 cells) 10% (n=435 cells) 
Mosaic germline clones stage 5-8 31% (n=136 cells) 6% (n=136 cells) 
Follicle cell clones stage 8-10 37% (n=410 cells) 12% (n=449 cells) 
Genotype
FRT18D/FRT18Ddm2 18D/dm2 18D
Germline clones stage 5-8 28% (n=630 cells) 10% (n=435 cells) 
Mosaic germline clones stage 5-8 31% (n=136 cells) 6% (n=136 cells) 
Follicle cell clones stage 8-10 37% (n=410 cells) 12% (n=449 cells) 

Ovaries containing germline or follicle cell clones were incubated with BrdU for one hour. BrdU incorporation was detected using an anti-BrdU antibody. Frequency of BrdU incorporation in wild-type clones (FRT18D) is compared with dm2 clones (dm2 FRT 18D)of approximately the same stage. Results are expressed as the percentage of BrdU-positive cells per total number of clonal cells.

Close Modal

or Create an Account

Close Modal
Close Modal